Net income Yuhan 2015-2022
In 2022, South Korean pharmaceutical company Yuhan Co, Ltd. reported a net income of around 130.3 billion South Korean won. This represents an increase from the previous year.
In 2022, South Korean pharmaceutical company Yuhan Co, Ltd. reported a net income of around 130.3 billion South Korean won. This represents an increase from the previous year.
You only have access to basic statistics.
This statistic is not included in your account.
Business Solutions including all features.
Overview
International trade
Pharmaceutical sales
Pharmaceutical expenditure of the National Health System
Research and development
Company rankings
Further related statistics